Accepting patients in Newport Beach. Schedule a complimentary 15-minute phone consultation (949) 558-0501
Home / Blog / Cancer Screening
Cancer Screening · Guideline Guide

Colonoscopy Screening Guidelines: When to Start and How Often

Man in his late forties walking on a sunlit coastal path in the morning
The short answer

Average-risk screening now starts at 45, and a normal colonoscopy buys you ten years before the next one. Polyps shorten that interval. Screening continues through 75, then becomes an individual decision through 85. If the prep is what keeps stopping you, stool and blood tests are legitimate options, because the test you complete beats the perfect test you postpone. But a positive stool or blood test always means a colonoscopy.

The sentence we hear most is not "I'm worried about colon cancer." It is "I know, I know, I'm overdue." Usually said with a small wince, sometimes with a story about a friend's prep, almost always followed by a change of subject. Colon cancer screening has an unusual problem for a screening test: nearly everyone agrees it works, and a large share of people who should have had one have quietly decided to deal with it next year.

That is worth taking seriously rather than scolding, because the guidelines have moved and most people have not been told. The start age is lower than it was for your parents. There are more ways to be screened than there used to be, and they are not equivalent. This is what the recommendations actually say, and where the trade-offs really sit.

Why screening now starts at 45, not 50

In 2021 the US Preventive Services Task Force lowered the recommended start age for average-risk adults from 50 to 45, a B grade for ages 45 to 49 alongside its long-standing A grade for ages 50 to 75. The American Cancer Society had already moved to 45 in 2018 and reaffirmed it in its 2026 guideline update. When those two bodies agree, the answer is settled: if you are 45 and have not been screened, you are due now.

The reason for the change is not enthusiasm. It is that colorectal cancer is behaving differently in younger adults. The American Cancer Society's 2026 colorectal cancer statistics report describes incidence rising roughly 3% per year in adults aged 20 to 49 and about 0.4% per year in adults 50 to 64, while falling about 2.5% per year in adults 65 and older. Screening the older group has worked. The younger group is where the disease has been migrating, and the rise has been dominated by tumors in the distal colon and rectum.

Nobody has a complete explanation for that trend yet, and you should be skeptical of anyone selling you one. What is clear enough to act on is the arithmetic: a cancer that takes about a decade to develop from a polyp is showing up in people in their forties, so the screening net moved earlier.

Who needs to start before 45

Family history moves your start date, and it is the single most common thing a rushed visit gets wrong. If you have a first-degree relative (parent, sibling, or child) diagnosed with colorectal cancer or an advanced polyp before age 60, or two first-degree relatives diagnosed at any age, gastroenterology guidance is to begin at age 40, or ten years before the age at which your youngest affected relative was diagnosed, whichever comes first, and to repeat colonoscopy every five years rather than ten. If your single affected relative was diagnosed at 60 or later, the guidance is gentler: start at 40, but the usual average-risk options and intervals still apply.

The detail that matters is specificity. "Cancer runs in my family" is not a history. Which relative, which cancer, and at what age are what change the plan. A father diagnosed at 52 puts you at 42. Two affected first-degree relatives, a relative diagnosed very young, or a pattern that includes uterine cancer raises the question of Lynch syndrome or another inherited syndrome, which calls for genetic evaluation and a far more intensive schedule than any guideline for average-risk adults. We walk through that in our guide to hereditary cancer genetic testing. Inflammatory bowel disease and prior abdominal radiation also pull the start date earlier.

Ten years, unless your results say otherwise

A complete, high-quality colonoscopy with no polyps found earns a ten-year interval. That number is not a bureaucratic convenience; it reflects how long a polyp typically takes to become a cancer. It is also, in practice, one of the best deals in preventive medicine: one unpleasant morning, a decade of coverage.

Findings shorten it. Under the 2020 US Multi-Society Task Force surveillance recommendations, one or two small tubular adenomas under 10 mm generally means a repeat in seven to ten years; three or four means three to five years; five to ten means three years. An advanced adenoma, meaning one 10 mm or larger, one with villous features, or one with high-grade dysplasia, means three years. Prep quality counts too: an inadequate prep means the exam did not see what it needed to see, and the interval resets rather than extending.

So "my colonoscopy was clean" is not one thing. Ask for the pathology result and the recommended next date in writing, and make sure it lands somewhere other than your memory.

When it stops is the part almost nobody is told. The Task Force recommends screening through age 75, then selectively offering it from 76 to 85 based on overall health, prior screening history, and preference (a C grade), and does not support routine screening beyond that. The 2026 American Cancer Society update frames it the same way: continue through 75 when life expectancy exceeds ten years, individualize from 76 to 85, and stop after 85. The logic is honest and slightly uncomfortable. The benefit of finding a polyp accrues over about a decade. The risks of a bowel prep and sedation arrive on the day. Past a certain point, that trade stops favoring the test, and the deciding factor is health and life expectancy rather than a birthday.

Worth saying plainly

A positive stool or blood test is not a diagnosis, and it is not a reason to wait and repeat it. It means you need a colonoscopy, and the 2026 American Cancer Society update asks for that colonoscopy within about six months. A screening program that ends at "the stool test was positive, let's recheck next year" is not a screening program. It is a stalled one.

Hands slicing fresh green vegetables on a wooden board in a sunlit kitchen

Every test on the menu, honestly ranked

All of the options below are endorsed screening strategies. They are not equally good, and the differences are worth understanding before you choose.

OptionThe honest assessment
Colonoscopy, every 10 yearsThe only test that finds and removes precancerous polyps in the same sitting, which is why it prevents cancer rather than only catching it. In the NordICC randomized trial, an invitation to a single colonoscopy cut ten-year colorectal cancer risk by 18%, and among people who actually attended, by about 31%. Costs: bowel prep, sedation, a day.
FIT (stool), annuallyNo prep, no sedation, no day off. Sensitivity for existing cancer is roughly 74%, with high specificity. Its weakness is precancerous polyps, which it mostly misses. It only works as a program if you genuinely do it every single year.
FIT-DNA (Cologuard), every 3 yearsBetter cancer sensitivity than FIT (around 92% in the pivotal trial) and better polyp detection (about 42% of advanced adenomas), but lower specificity, so more false positives and more people sent for a colonoscopy that finds nothing.
CT colonography, every 5 yearsGenuinely sees polyps, no sedation. You still do the bowel prep, anything found means a colonoscopy anyway, and it picks up incidental findings elsewhere in the abdomen that generate their own workups.
Blood-based test (Shield), every 3 yearsFDA approved in July 2024, the first blood test approved as a primary screening option. In the ECLIPSE study it detected about 83% of colorectal cancers, but only 13% of advanced adenomas. That is the whole story: it is a cancer-detection test, not a cancer-prevention test. The 2026 ACS guideline places it as an option for people who decline or do not complete the preferred tests.
Waiting until you have symptomsNot a strategy. By the time colorectal cancer causes bleeding, pain, or a persistent change in bowel habits, it is usually past the stage screening exists to find. This is the row that costs people the most.

Two conclusions follow. First, the best screening test is the one you will actually complete, and a completed FIT beats a colonoscopy you have been meaning to schedule since 2022. Second, the tests are not interchangeable in what they do. Colonoscopy removes the thing that would have become cancer. The blood test looks for cancer that already exists. Both are worth having; only one of them is prevention. The same distinction runs through our look at multi-cancer blood screening tests.

How this works at Framework Health

We do not perform colonoscopies. What we do is make sure the right test happens, on the right schedule, with the result read properly.

  1. Establish your real risk before choosing a test. A proper family history takes several minutes: which relative, which cancer, what age at diagnosis, plus polyp history, symptoms, and inflammatory bowel disease. Hour-long visits exist so this does not get skipped.
  2. Choose the test you will actually complete. If colonoscopy is right and you will do it, we refer and coordinate. If the honest answer is that you will not, we would rather have you on an annual FIT than on a plan that never happens.
  3. Order, coordinate, and check coverage first. We arrange the referral, send your history to the gastroenterologist, and confirm what your plan covers before you commit to anything.
  4. Read the whole report and own the follow-up. Pathology, prep quality, and the recommended interval all go into your chart with a date attached, so the next one is our job to track, not something you have to remember a decade from now.

Questions we hear about this every week

The prep is the reason I keep putting this off. Is that normal?
It is the most common reason people delay, and it is a legitimate complaint rather than a character flaw. Modern split-dose and lower-volume preps are considerably easier than the ones people remember from a decade ago, and the procedure itself is done under sedation and is not painful. If the answer is still no, an annual stool test is a real screening plan and far better than nothing.
Is Cologuard as good as a colonoscopy?
No, and it is not meant to be. FIT-DNA testing detected about 92% of colorectal cancers in its pivotal trial but only about 42% of advanced precancerous polyps, and it cannot remove anything it finds. It is a good screening test with a shorter three-year interval, and a positive result means you need a colonoscopy.
Can I just get the blood test instead?
You can, and for some people it is the right call, but understand what you are choosing. The FDA-approved Shield blood test detected about 83% of colorectal cancers in the ECLIPSE study and only about 13% of advanced precancerous polyps. The 2026 American Cancer Society guideline recommends it specifically for people who decline or do not complete the preferred tests, because it detects cancer rather than preventing it.
My father had colon cancer at 55. When do I start?
At 45 in that example, because guidance for people with a first-degree relative diagnosed before age 60 is to begin at age 40 or ten years before the youngest affected relative's diagnosis, whichever comes first. You would also repeat colonoscopy every five years rather than ten. Bring the actual ages of diagnosis to your visit; they change the plan more than anything else you can tell us.
I am 78 and in good health. Should I keep screening?
Probably, and it is genuinely an individual decision. Guidelines recommend screening through 75, then selectively offering it from 76 to 85 based on your overall health, prior screening, and preferences. The relevant question is life expectancy and how you feel about the trade, not the number on your birthday.

The bottom line

Colorectal cancer is one of the few common cancers that screening can prevent outright rather than merely catch early, which is why the delay most people quietly grant themselves is expensive. Start at 45 unless family history moves you earlier. A normal colonoscopy is good for ten years; polyps shorten that, and the report will tell you by how much. Keep going through 75 and then decide with someone who knows your health. And if the prep is what has been stopping you, take the stool test this year instead of taking nothing again. For a companion guide to the other screening most people over 45 are behind on, see our mammogram screening guide.

Get the one you keep deferring on the calendar

Framework Health orders, coordinates, and tracks cancer screening for members in Newport Beach, with hour-long visits and follow-up that actually happens. Consult calls are free.

DS
Devan Stetson, PA-C

Certified Physician Assistant and Menopause Society Certified Practitioner at Framework Health, a concierge primary care and healthy aging practice in Newport Beach, California. This article is educational and is not a substitute for personal medical advice.

References
  • US Preventive Services Task Force, final recommendation statement on colorectal cancer screening, 2021 (grade A ages 50 to 75, grade B ages 45 to 49, grade C ages 76 to 85)
  • Wolf AMD, Hoffman RM, Walter LC, et al. Colorectal cancer screening: an update to the American Cancer Society guideline, 2026. CA: A Cancer Journal for Clinicians, 2026;76(3):e70083 (start at 45, blood-based tests only for those who decline preferred tests, follow-up colonoscopy preferably within 6 months)
  • Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, 2020;158(4):1131-1153 (surveillance intervals after polyps)
  • Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology, 2017;153(1):307-323 (family history start age and five-year interval)
  • Bretthauer M, Løberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death (NordICC). New England Journal of Medicine, 2022;387(17):1547-1556 (18% reduction on intention to screen, about 31% among those who attended)
  • Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. New England Journal of Medicine, 2014;370(14):1287-1297 (FIT-DNA 92.3% and FIT 73.8% sensitivity for cancer; 42.4% for advanced precancerous lesions)
  • Chung DC, Gray DM, Singh H, et al. A cell-free DNA blood-based test for colorectal cancer screening (ECLIPSE). New England Journal of Medicine, 2024;390(11):973-983 (83.1% sensitivity for colorectal cancer, 13.2% for advanced precancerous lesions, 89.6% specificity)
  • FDA premarket approval of the Shield blood-based colorectal cancer screening test, PMA P230009, approved July 26, 2024
  • Siegel RL, Wagle NS, Star J, Kratzer TB, Smith RA, Jemal A. Colorectal cancer statistics, 2026. CA: A Cancer Journal for Clinicians, 2026;76(2):e70067 (incidence trends by age group)
Call Text Book consult